Home › Trial NCT01575925
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
- Trial IDNCT01575925
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorCelgene
- Enrollment25
- Start date2012-06-01
- ConditionsMultiple Myeloma · Renal Impairment
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.